Orchestra BioMed Holdings, Inc. Ordinary Shares vs. ResMed Inc.
Orchestra BioMed Holdings, Inc. Ordinary Shares and ResMed Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| OBIO | RMD | |
|---|---|---|
| Market Cap | $326.37 million | $31.89 billion |
| Revenue (TTM) | — | $5.65 billion |
| Net Income (TTM) | — | $1.52 billion |
RMD leads on 1 of 1 size & scale factors.
Valuation
| OBIO | RMD | |
|---|---|---|
| P/E Ratio | — | 21.13 |
| Price / Book | — | 4.84 |
| Price / Sales | — | 5.64 |
OBIO and RMD split the valuation factors evenly.
Profitability
| OBIO | RMD | |
|---|---|---|
| Net Margin | — | 26.94% |
| Return on Equity | — | 23.13% |
OBIO and RMD split the profitability factors evenly.
Dividend
| OBIO | RMD | |
|---|---|---|
| Dividend Yield | — | 1.20% |
| Payout Ratio | — | 25.31 |
OBIO and RMD split the dividend factors evenly.
Risk & Sentiment
| OBIO | RMD | |
|---|---|---|
| Short Interest | 0.05% | 4.04% |
OBIO leads on 1 of 1 risk & sentiment factors.
Dig deeper: OBIO overview, OBIO financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.